48-Week Off-Therapy Efficacy and Safety of Bulevirtide in Combination with Pegylated Interferon Alfa-2A in Patients with Chronic Hepatitis Delta: Final Results from the Phase 2b, Openlabel, Randomised, Multicentre Study MYR204Tarik Asselah,Vladimir Chulanov,Pietro Lampertico,Heiner Wedemeyer,Adrian Streinu-Cercel,Victor Pantea,Stefan Lazar,George Sebastian Gherlan,Pavel Bogomolov,Tatyana Stepanova,Viacheslav Morozov,Vladimir Syutkin,Olga Sagalova,Dmitry Manuilov,Renee-Claude Mercier,Lei Ye,Grace M. Chee,Ben L. Da,Audrey H. Lau,Anu Osinusi,Marc Bourliere,Vlad Ratziu,Stanislas Pol,Marie-Noelle Hilleret,Fabien ZoulimJOURNAL OF HEPATOLOGY（2024）引用 0|浏览3AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
